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a b s t r a c t
A strain of the porcine cytomegalovirus (PCMV), which causes inclusion body rhinitis in newborn piglets,
has been characterized with respect to its complete genome sequence. The virus genome is 128,367 bp,
containing 79 predicted open reading frames (ORFs). Of these ORFs, 69 have counterparts in human
herpesvirus 6A (HHV-6A), 6B (HHV-6B) and 7 (HHV-7), and two ORFs are homologous to other members
in the subfamily Betaherpesvirinae. Eight ORFs have no homologs in herpesvirus. Homologs had higher
identity and possessed similar orientation and location as roseoloviruses. The PCMV genome is a DR-U-
DR type, similar to HHV-6A, HHV-6B and HHV-7, but the PCMV DR is shorter and lacks predicted genes
and telomere-like sequences. Phylogenetic analyses of several core genes indicate that PCMV could be
clustered in a branch with roseoloviruses. We suggest that PCMV could be classiﬁed as a member of the
genus Roseolovirus of the subfamily Betaherpesvirinae.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Porcine cytomegalovirus (PCMV), ﬁrst described by Done (1955),
is an important pathogen that causes inclusion body rhinitis and
generalized infection in newborn piglets, and more severely, fetal
death due to in utero infection in sows. The virus also can cause
subclinical infection in adult pigs. PCMV infections are distributed
worldwide, with a high prevalence in swine herds. Similar to other
herpesviruses which are difﬁcult to eliminate completely from the
host, PCMV can be reactivated in vivo by stress (Mueller et al., 2004;
Narita et al., 1987). In human xenotransplantation, signiﬁcant atten-
tion has been paid to cross-species transmission of PCMV and its
potential risk to public health (Gollackner et al., 2003).
PCMV was classiﬁed into the subfamily Betaherpesvirinae of the
family Herpesviridae based on its biological properties in vivo and
in vitro (Roizman et al., 1992). The virus remains as an unassigned
species in Betaherpesvirinae according to the Ninth Report of the
International Committee on Taxonomy of Viruses (ICTV) (Pellett et
al., 2012). To date, only three genes encoding for DNA polymerase,
major capsid protein, and glycoprotein B have been identiﬁed in
the PCMV genome. These genes were more identical to human
herpesvirus 6A (HHV-6A), 6B (HHV-6B) and 7 (HHV-7) in the
genus Roseolovirus than with members of the Cytomegalovirus or
Muromegalovirus genera, such as human cytomegalovirus (HCMV),
mouse cytomegalovirus (MCMV) and rat cytomegalovirus (RCMV)
(Goltz et al., 2000; Rupasinghe et al., 1999, 2001; Widen et al.,
2001). These limited ﬁndings suggested that PCMV might be
included within the genus Roseolovirus, along with HHV-6A,
HHV-6B and HHV-7 (Rupasinghe et al., 1999, 2001; Widen et al.,
2001). Therefore, analyzing and molecularly characterizing the
PCMV genome is essential for deﬁning the viral genus and
exploring its genetic function and molecular pathogenesis.
Materials and methods
Virus culture and DNA preparation
PCMV strain BJ09 was isolated from pulmonary alveolar macro-
phages (PAMs) of a 4-week-old pig without obvious clinical
symptoms. Available PAMs which were positive for PCMV accord-
ing PCR were used to amplify a 314-bp fragment of the DNA
polymerase (DPOL) gene (Hamel et al., 1999). PT-K75 cells (ATCC)
were infected with PCMV by co-culturing with PAMs and then
passaged six times with seven days’ culture each time to obtain a
higher virus titer. For viral DNA preparation, PCMV-infected PT-
K75 cells were treated with Triton X-100 (Sigma-Aldrich, St. Louis,
MO, USA) and micrococcal nuclease (NEB, Ipswich, MA, USA)
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before extracting DNA with phenol and chloroform as described
previously (Sinzger et al., 1999).
Animal use for this study was approved by The Beijing
Municipal Committee of Animal Management and The Ethics
Committee of China Agricultural University.
DNA sequencing and assembling
First, 4 μg of PCMV DNA was used to prepare a paired-end
library with a 500-bp insert size and to generate read lengths of
90 bp. High-throughput Illumina Genome AnalyzerIIX paired-end
sequencing was performed in BGI (Shenzhen, China) to sequence
the complete PCMV genome. After ﬁltering, the 90-bp reads were
assembled with SOAPdenovo software (BGI) to four contigs.
To close the gaps (usually less than 20 bp), conventional PCR was
applied by designing speciﬁc primers. Simultaneously, with the
Genome Walking Kit (Takara, Dalian, China), the gaps between the
contigs were closed.
After aligning with HHV-6A, HHV-6B and HHV-7, the 50-RACE
and 30-RACE ampliﬁcations were carried out using a Marathon
cDNA ampliﬁcation Kit (Clontech, Mountain View, CA) as pre-
viously described (Davison et al., 2003). Brieﬂy, the genomic DNA
was ﬂush-ended with T4 DNA Polymerase (Promega, Madison, WI)
and ligated to the Marathon adaptor, and then the adaptor primers
plus PCMV speciﬁc primers were used to identify the termini. Finally,
using viral DNA extracted from PCMV-infected cells as templates, the
DR-DR junction was ampliﬁed by PCR and sequenced with designed
speciﬁc primers (50-ACTGCACCGCTTCCCTTTAA-30 and 50-ATCACCAG-
CAGGCACCGTAT-30) to conﬁrm the Marathon results.
Genomic analyses
For the complete genome, GeneMarkS, a self-training program
for predicting gene starts [Georgia Institute of Technology (http://
exon.gatech.edu/genemarks.cgi)] (Besemer et al., 2001), was
applied to identify ORFs, all of which had ATG as the start codon.
At least 60 codons were analyzed for homologs using the BLASTP
program (NCBI). Genes were designated according to their coun-
terparts in HHV-6A, HHV-6B and HHV-7 or their positions within
the genome. Searches for poly(A) signals, promoters, and splice
sites were conducted by submitting the genomic sequence to
PolyADQ, a eukaryotic polyadenylation signal search engine [Cold
Spring Harbor Laboratory (http://rulai.cshl.org/tools/polyadq/poly
adq_form.html)], the Berkeley Drosophila Genome Project’s Neural
Network Promoter Prediction program (http://www.fruitﬂy.org/
seq_tools/promoter.html), a human promoter search engine and
the Berkeley Drosophila Genome Project Splice Site Prediction by
Neural Network, a eukaryotic search engine for donor and accep-
tor splice sites (http://www.fruitﬂy.org/seq_tools/splice.html)
(Tabaska and Zhang, 1999).
Sequence alignments for phylogenetic analysis were carried out
with the ClustalX 1.83 program. Phylogenetic trees were generated
using the neighbor-joining method, bootstrap1000, of the MEGA
6 program. All herpesviruses used in our genomic analyses and
their accession numbers are as follows: HHV-6A [GenBank no:
KC465951.1], HHV-6B [GenBank no: AF157706.1], HHV-7 [GenBank
no: AF037218.1], HCMV [GenBank no: AY446894.2], MCMV [Gen-
Bank no: GU305914.1], RCMV [GenBank no: AF232689.2], cerco-
pithecine herpesvirus 5 (CeHV-5) [GenBank no: FJ483968.2],
macacine herpesvirus 3 (RhCMV) [GenBank no: JQ795930.1],
panine herpesvirus 2 (PaHV-2) [GenBank no: AF480884.1], ele-
phantid herpesvirus 1A (ElHV-1A) [GenBank no: KC462165.1],
elephantid herpesvirus 1B (ElHV-1B) [GenBank no: KC462164.1]
and rhinolophus ferrumequinum betaherpesvirus (RfBHV-1)
[GenBank no: JQ814845].
Results and discussion
Genome organization of PCMV BJ09
The raw data with 100 Mb was obtained by the high-
throughput sequencing of PCMV BJ09 genome. After ﬁltering and
analyzing, the depth of the sequencing approximately reached
500 , which is sufﬁcient for genome assembling. To identify the
positions of the genomic termini, a 50-RACE fragment with 510 bp
and a 30-RACE fragment with 523 bp were ampliﬁed (Fig. 1A). The
locations of the termini were determined and the DR of the PCMV
genome was identiﬁed by sequencing the ampliﬁed fragments.
The DR–DR junction fragment with 1375 bp was ampliﬁed and
sequenced (Fig. 1B).
The complete PCMV BJ09 genome was assembled and depos-
ited into the GenBank database [GenBank no: KF017583]. The virus
genome is 128,367 bp, shorter than those of HHV-6A (159,322 bp),
HHV-6B (162,114 bp) and HHV-7 (153,080 bp), with a higher
GþC content (45.54%), compared with HHV-6A/U1102 (42.44%),
HHV-6B/z29 (42.77%), and HHV-7/RK (36.22%). The draft genome
of PCMV is shown in Fig. 2. The genome contains a unique
127,641 bp region, ﬂanked by a 363-bp direct repeat (DR)
sequence that is shorter than those of HHV-6A, HHV-6B, and
HHV-7. Homologous region related to the mammalian telomeric
sequence was not identiﬁed in the DR of PCMV, whereas this
region was found in HHV-6A, HHV-6B and HHV-7 (Megaw et al.,
1998). In the unique region, 79 genes/ORFs were predicted by the
GeneMarkS program, and the majority of these genes have homo-
logs in HHV-6A, HHV-6B, and HHV-7 in amino acid composition
and sequence (Table 1).
The DNA repeats were determined by the sequencing method
with 500 bp random fragments. The deﬁned 15 repetitive ele-
ments within the PCMV genome are mainly located in two regions
—U77–U79 and U86–U100p (Fig. 2). All of them are shorter than
500 bp in length. The details of these repeats are summarized in
Table 2. These elements are inferred to affect the transcriptional
process of PCMV (Isegawa et al., 1999; Nicholas, 1996). Out of these
elements, four (designated R3, R7, R11 and R15) are considered to
be perfect consecutive direct repeats; the R15 was found to locate
between two poly(A) signals from convergent transcripts, inferring
that it might play a role in preventing accidental read-through by
RNA polymerase into the oppositely transcribed gene (Klupp et al.,
2004). Both the R3 (KpnI) of HHV-6A and HHV-6B and R2 (DraI) of
Fig. 1. Identiﬁcation of the genomic termini positions. (A) The ampliﬁcations of 50-
RACE and 30-RACE by a Marathon cDNA ampliﬁcation Kit. Lane 1: DNA marker. Lane
2: 30-RACE product of 523 bp. Lane 3: 50-RACE product of 510 bp. (B) Ampliﬁcation
of the PCMV DR-DR junction by PCR. Viral DNA was extracted from PCMV-infected
cells. PCR was performed using the designed speciﬁc primers (50-ACTG-
CACCGCTTCCCTTTAA-30 and 50-ATCACCAGCAGGCACCGTAT-30). Lane 1: DNA mar-
ker. Lane 2: a 1375 bp product. Lane 3: uninfected cell control.
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HHV-7 have been recognized to be cis-acting enhancers located
upstream of IE-A (Isegawa et al., 1999; Nicholas, 1996; Takemoto
et al., 2001), and are common in betaherpesviruses (Isomura et al.,
2004). The R11 and R15 of PCMV are shown to contain 4 and 3 StuI
restriction endonuclease sites at the similar locations to betaher-
pesviruses, respectively, inferring that these sites may act as
cis-acting elements.
ORFs within the PCMV BJ09 genome
Seventy-nine ORFs within the PCMV genome were predicated,
and the information of these ORFs is shown in Table 1. Using the
BLASTP program, the majority of the PCMV ORFs were identiﬁed to
have homologs in herpesviruses, mainly in HHV-6A, HHV-6B and
HHV-7, except for the eight ORFs (U13p, U24p, U26p, U83p, U85p,
U89p, U90p and U100p) with a sufﬁx “p”. Moreover, the whole
genomic organization of PCMV is virtually identical to HHV-6A,
HHV-6B and HHV-7, showing a DR-U-DR type, and meanwhile, the
gene arrangement in the unique region of PCMV genome is similar
to the unique long regions of HCMV, RCMV and MCMV. These
homologous genes share greater identities with betaherpesviruses
including HHV-6A, HHV-6B, HHV-7, HCMV, RCMV and MCMV than
alpha- and gamma-herpesviruses. In alpha-, beta- and gamma-
herpesviruses, 43 conserved genes inherited from a common
ancestor are present and referred as “core genes”, whereas other
genes are referred to as “non-core genes”. Compared with HHV-
6A, HHV-6B and HHV-7, the core genes of PCMV are more
conserved and the non-core genes located in the PCMV genome
termini have counterparts in HCMV, RCMV and MCMV, in which
some genes belonging to the US22 family might be involved in
gene regulation (Megaw et al., 1998).
In HHV-6A, HHV-6B and HHV-7, the genes at the same posi-
tions with the eight PCMV ORFs without homologs encode for
transcriptional repressor (U13), membrane proteins (U24, U26), CC
chemokine (U83), glycoproteins (U85, U100) and IE-A proteins
(U89, U90). These genes are non-core genes and are less conserved
in betaherpesviruses. Of these genes, an ORF (U83p) is present,
whereas other seven ORFs (U18, U20, U23, U45, U47, U55 and U91)
are absent in PCMV, compared with HHV-7. In addition to the
seven ORFs, additional four genes (U6, U9, U22 and U94) in HHV-
6A and HHV-6B are absent in PCMV. In this regard, PCMV is more
closely related to HHV-7 than HHV-6A and HHV-6B.
Of the 79 genes identiﬁed in PCMV, 73 have promoters
predicted by a program trained with human core promoter
sequences, and the remaining genes have not core promoters,
possibly due to a long or spliced 50 UTR, a TATA-less promoters,
and/or a poorly scoring promoter.
Searching for polyadenylation [poly(A)] signals conducted by
the PolyADQ program indicated that all genes are tailed with
poly(A) signals at the 30 terminus. All the 79 genes share 67 poly
(A) signals at different positions. Among the 79 genes, 62 genes
have the poly(A) signals with AATAAA sequences, and the remain-
ings have ATTAAA sequences. Further investigation of S1 nuclease
transcript mapping and cDNA sequencing are essential for deter-
mining the poly(A) cleavage site and the 30 UTR length.
The U60/66, U16/17 and U79 of PCMV are homologous with
HHV-6A, HHV-6B and HHV-7, which may share the similar spliced
patterns. Splicing of U60/66 and U16/17 has been conﬁrmed in
HHV-6A, HHV-6B, HHV-7 and herpes simplex virus type 1 (Dolan
et al., 1991; Menegazzi et al., 1999; Megaw et al., 1998; Mirandola
et al., 1998). Thus, we predicted the most likely spliced sites in
PCMV U60/66 and U16/17 (Table 3). Additionally, U12, U15, U79 of
HHV-6A, HHV-6B, HHV-7 and HCMV and their homologs are
thought to be spliced (Isegawa et al., 1999; Megaw et al., 1998),
whereas the three genes of PCMV are shorter than these viruses
and have no spliced component except for a potential one at the
terminus of U79 (Table 3) by the amino acid alignment. The region
between U86 to U100p in PCMV has no homologous ORFs of HHV-
6A, HHV-6B and HHV-7 except for U86 and U95. The potential
homologs of U89p, U90p and U100p in PCMV are not present in
other herpesviruses by aligning the conceptual translation pro-
ducts of PCMV using the BLASTP program. Thus, the predicted
possible spliced sites of U89p/90p and U100p are shown in Table 3.
The gQ genes (U100) of HHV-6A, HHV-6B and HHV-7 are highly
spliced, whereas more than 10 pairs of splicing donors and
acceptor sites indicate complicated splicing patterns in this region
Fig. 2. Genetic organization of the PCMV genome. Arrows represent predicted ORFs and indicate the location and orientation. Arrows with white rectangles are the core
genes. The direct repeat of the terminus (DR, white rectangles), the repeat elements (R1–R15, gray rectangles) and the origin of DNA replication (Ori, black circle) are also
identiﬁed.
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Table 1
Predicted ORFs within the PCMV genome.
ORFa Strand Position Length (aa)c Identity (% Id)d with [length of aligned region
(aa)]
Homologs in HCMV Comments
Start Stop Poly(A) signalb Promoter HHV-6A HHV-6B HHV-7
U1§ þ 484 1,887 2,005 298–348 468 23 [300]
(RCMV R25)
26 [329]
(MCMV M25)
22[297]
(HCMV UL25)
UL25 UL25 family; tegument phosphoprotein
U2  3,020 2,046 2,024 3,279–3,229 324 33 [260] 30 [295] 31 [271] UL23 US22 family; tegument protein
U3A  3,996 3,067 3,005 – 309 34 [302] 34 [302] 34 [288] UL24 US22 family; tegument protein
U3B  4,573 3,959 3,841 4,578–4,628 204 26 [140] 25 [144] – UL24 US22 family; tegument protein
U4  6,120 4,558 3,841 6,397–6,347 520 39 [538] 39 [532] 37 [527] UL27 Maribavir resistance
U5  8,885 6,177 6,157* 9,286–9,236 902 26 [849] 26 [865] 27 [848] UL28 Unknown function
U8  10,051 8,882 6,157* 10,068–10,118 389 28 [339] 27 [339] 27 [332] UL29 US22 family
U10 þ 10,281 11,687 11,699 9,391–9,441 468 36 [401] 35 [444] 33 [441] UL31 DURP family; HHV-7 IE gene
U11  13,810 11,705 11,553 13,988–13,938 701 26 [268] 27 [293] 26 [260] UL32 Tegument protein pp100; antigenic virion protein;
binds to capsids
U12 þ 14,300 15,091 15,613 14,032–14,082 263 31 [231] 31 [257] 36 [241] UL33 Envelope protein; GPCR family, G protein-coupled
receptor homolog
U13p# þ 15,094 15,495 15,613 – 133 – – – – Putative protein; unknown function
U14 þ 15,527 16,852 17,449 – 441 23 [333] 25 [334] 26 [268] UL35 UL25 family; tegument phosphoprotein; interacts
with UL82 protein
U15  17,546 17,247 17,216 17,775–17,825 99 37 [89] 35 [92] 29 [96] – Unknown function
U16  18,423 17,635 17,603 18,696–18,746 262 31 [259] 32 [260] 29 [257] UL36 US22 family; IE-B, transactivator
U17  18,695 18,405 17,603 18,220–18,170 97 35 [51] 35 [51] 24 [70] UL36 IE-B
U19  20,933 19,902 19,816* 20,986–20,936 343 34 [178] 37 [164] 32 [165] UL38 IE-B
U21  22,359 21,094 20,997 22,432–22,382 421 23 [389] 22 [375] 18 [382] – Membrane glycoprotein
U24p#  23,467 22,433 20,997 23,667–23,617 344 – – – – Putative protein; unknown function
U25  25,332 24,361 23,960* 25,532–25,482 323 30 [274] 30 [274] 34 [284] UL43 US22 family; tegument protein
U26p#  26,323 25,469 23,960* 26,509–26,459 284 – – – – Putative protein; unknown function
U27  27,372 26,317 23,960* 27,467–27,417 351 50 [351] 50 [351] 49 [351] UL44 DNA polymerase processivity subunit, pp41
U28  29,919 27,502 23,960* – 805 31 [770] 30 [768] 31 [772] UL45 Tegument; large subunit of ribonucleotide
reductase homolog (enzymatically inactive)
U29  30,782 29,925 29,860 31,219–31,169 285 38 [288] 37 [288] 34 [286] UL46 Component of capsid triplexes (minor capsid
binding protein; TRI1)
U30 þ 30,784 33,606 35,757* 30,375–30,425 940 26 [951] 27 [957] 28 [939] UL47 tegument; intracellular capsid transport
U31 þ 33,603 39,752 40,312* 32,259–32,309 2049 29 [2134] 28 [2132] 30 [2125] UL48 Large tegument protein; intracellular capsid transport
U32  40,003 39,761 39,751 39,380–39,330 81 48 [54] 48 [54] 56 [54] UL48A Located on tips of hexons in capsids; capsid transport
U33  41,415 40,006 39,765 41,562–41,512 469 45 [466] 44 [466] 43 [476] UL49 Virion protein essential for replication of HCMV
U34  42,163 41,366 39,765 42,312–42,262 265 50 [181] 50 [181] 43 [260] UL50 Putative virion protein; inner nuclear membrane protein;
nuclear egress of capsids in MCMV
U35  42,484 42,170 39,765 42,566–42,516 104 44 [96] 44 [96] 49 [90] UL51 DNA packaging protein; terminase-binding
U36 þ 42,486 43,946 44,792 41,746–41,796 486 44 [487] 44 [487] 47 [489] UL52 Putative virion protein; Capsid transport
U37 þ 43,939 44,706 44,792 43,550–43,600 255 50 [227] 47 [254] 49 [253] UL53 Nuclear egress lamina protein
U38  47,751 44,728 44,718* 47,884–47,834 1007 51 [1017] 51 [1019] 51 [1010] UL54 DNA polymerase catalytic subunit
U39  50,092 47,762 47,238 50,481–50,431 776 44 [797] 44 [797] 41 [796] UL55 Glycoprotein B
U40  52,475 50,298 49,796 52,660–52,610 725 45 [733] 45 [729] 43 [725] UL56 Transport protein; DNA packaging terminase subunit 2
U41  55,889 52,503 52,484 56,247–56,197 1128 49 [1137] 49 [1137] 51 [1114] UL57 Single-stranded DNA-binding protein
U42  58,491 56,854 56,803 58,689–58,639 545 30 [545] 40 [311] 30 [532] UL69 Transactivator; tegument protein; contributes to cell cycle block;
exhibits nucleocytoplasmic shuttling
U43  61,130 58,575 58,553 61,408–61,358 851 46 [862] 46 [862] 46 [862] UL70 Helicase-primase complex; primase homolog (HP2)
U44 þ 61,173 61,805 61,929* 60,375–60,425 210 50 [173] 50 [173] 46 [173] UL71 Tegument protein; cytoplasmic egress
U46 þ 61,918 62,247 62,577 61,791–61,841 109 60 [55] 60 [55] 44 [63] UL73 Glycoprotein N
U48  64,486 62,438 62,417* 64,833–64,783 682 28 [710] 29 [690] 31 [706] UL75 Glycoprotein H
U49 þ 64,599 65,369 65,601 64,164–64,214 256 40 [248] 39 [248] 40 [199] UL76 Fusion protein
U50 þ 65,440 66,807 66,817* 65,100–65,150 455 44 [441] 45 [441] 44 [445] UL77 DNA packaging tegument protein; portal capping protein
U51 þ 66,867 67,772 67,874 – 301 22 [239] 22 [239] 23 [224] UL78 GPCR family; G-protein coupled receptor
U52  68,538 67,783 67,606 68,624–68,574 251 39 [254] 39 [254] 42 [237] UL79 Prereplication complexes
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U53 þ 68,537 70,291 71,310 66,860–66,910 584 31 [603] 31 [603] 30 [595] UL80 Protease (N terminus) and capsid assembly
(scaffold) protein (C terminus)
U54A  72,304 70,307 70,298 72,353–72,303 665 24 [333] 21 [451] 23 [405] UL82 DURP family; major tegument phosphoprotein, pp65
U54B§  73,541 72,354 72,263 73,730–73,880 395 26 [299]
(RCMV R84)
20[260]
(HCMV UL83)
– UL83 DURP family; major tegument phosphoprotein, pp65
U56  74,455 73,568 73,560 74,692–74,642 295 52 [295] 52 [295] 54 [295] UL85 Component of capsid triplexes
U57  78,472 74,456 73,697 78,571–78,521 1338 55 [1344] 55 [1344] 53 [1343] UL86 Major capsid protein
U58 þ 78,521 80,782 81,567 76,901–76,951 753 48 [754] 48 [754] 49 [744] UL87 Component of Prereplication complexes
U59 þ 80,769 81,800 82,032* 80,173–80,223 343 32 [322] 31 [348] 27 [335] UL88 Tegument protein; cytoplasmic egress
U60  82,700 81,801 81,704* 82,824–82,774 299 66 [301] 66 [301] 64 [301] UL89 Late spliced gene (U60/U66) for DNA packaging;
terminase ATPase subunit
U62 þ 82,943 83,170 83,705 82,800–82,850 76 42 [64] 40 [73] 39 [66] UL91 Unknown function
U63 þ 83,189 83,803 84,152 82,800–82,850 204 57 [189] 57 [189] 55 [191] UL92 Unknown function
U64 þ 83,763 85,124 85,678* 83,326–83,376 453 27 [454] 27 [455] 26 [451] UL93 Tegument protein; capsid transport
U65 þ 85,054 86,049 86,254 84,953–85,003 332 36 [335] 38 [336] 37 [333] UL94 Tegument protein; binds single-stranded DNA;
related to viral cell-to-cell spreading
U66  86,933 85,785 83,907 87,293–87,243 382 49 [294] 50 [296] 47 [294] UL89 Late spliced gene (U60/U66) for DNA packaging;
terminase ATPase subunit
U67 þ 86,932 87,963 88,145* 85,848–85,898 343 41 [347] 41 [347] 42 [339] UL95 Prereplication complexes; encapsidation
chaperone protein
U68 þ 87,974 88,330 88,382 87,545–87,595 118 33 [111] 32 [111] 32 [105] UL96 Tegument protein
U69 þ 88,367 89,899 90,036 88,196–88,246 510 37 [404] 37 [404] 37 [404] UL97 Tegument protein; viral serine-threonine protein kinase;
phosphorylates ganciclovir; roles in DNA synthesis,
DNA packaging and nuclear egress; mimics cdc2/CDK1 (VPK)
U70 þ 89,886 91,355 91,802 89,791–89,841 489 38 [491] 37 [503] 40 [484] UL98 Alkaline exonuclease
U71 þ 91,292 91,504 91,802 91,018–91,068 71 38 [58] 38 [53] 35 [46] UL99 Myristylated tegument phosphoprotein pp28;
cytoplasmic egress tegument protein; related to
viral cell-to-cell spreading
U72  92,555 91,524 90,965 92,708–92,658 343 42 [343] 43 [343] 43 [344] UL100 Glycoprotein M
U73 þ 92,566 94,938 94,995 92,406–92,456 790 45 [761] 45 [756] 45 [761] – DNA replication origin-binding protein; helicase
U74 þ 94,878 96,929 97,146 94,818–94,868 683 27 [656] 27 [656] 27 [692] UL102 Helicase–primase subunit (HP3)
U75  97,549 96,932 96,795 97,652–97,602 205 31 [197] 30 [197] 36 [160] UL103 Tegument protein; nuclear egress
U76  99,326 97,569 971,69 99,531–99,481 585 44 [560] 44 [559] 45 [562] UL104 Capsid portal protein
U77 þ 99,271 101,703 101,856 99,149–99,199 810 56 [827] 56 [827] 57 [823] UL105 Helicase–primase complex; helicase homolog (HP1)
U79 þ 10,4470 105,108 105,286 104,224–104,274 212 32 [182] 30 [182] 30 [132] UL112 UL113 Orchestration of DNA replication
U81  10,6307 105,552 105,538 106,384–106,334 251 52 [255] 52 [255] 47 [253] UL114 Uracil-DNA glycosylase
U82  10,7038 106,307 105,538 107,180–107,130 243 27 [172] 25 [224] 26 [235] UL115 Glycoprotein L
U83p#  10,8525 107,116 106,916 108,726–108,676 469 – – – – Putative protein; unknown function
U84  10,9488 108,682 108,279 109,772–109,722 268 37 [260] 37 [267] 37 [244] UL117 Putative glycoprotein
U85p#  11,0456 109,587 109,586 110,632–110,582 289 – – – – Putative protein; unknown function
U86  11,3945 110,793 110,661 – 1050 39 [230] 40 [218] 39 [220] UL122 IE-A; HCMV IE2 homolog
U89p#  11,4622 114,050 112,958 114,866–114,816 190 – – – – Putative protein; unknown function
U90p#  11,7180 115,471 115,300 117,411–117,361 569 – – – – Putative protein; unknown function
U95 þ 12,3195 124,658 124,869 122,415–122,465 487 27 [341] 31 [259] 31 [256] – US22 family; MCMV IE2 homolog; HHV-6 IE gene
U100p#  12,7060 126,581 126,222 127,222–127,172 159 – – – – Putative protein; unknown function
a ORFs are named according to their homologs of HHV-6 and HHV-7. The ones with “#” and a sufﬁx “p” have no identiﬁed homologs in other herpesviruses. “§” indicate the ORFs homologous to other members of
Betaherpesvirinae.
b Positions of the ﬁrst downstream polyadenylation signals (AATAAA or ATTAAA*) are indicated.
c The sizes of translation products for ORFs (starting at the N-terminal methionine) in amino acids (aa) are shown.
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of PCMV (Table 3). Some conserved splicing patterns in HHV-6A,
HHV-6B and HHV-7 are not present in the PCMV sequence, and
this may reﬂect their different evolutionary processes.
Immediate-early/regulatory genes of PCMV
The U86 and U95 of PCMV have homologs in IE-A genes (U86–
95) of HHV-6A, HHV-6B and HHV-7. IE-A genes are major
immediate early (MIE) genes and affect viral replication in all
betaherpesviruses (Isegawa et al., 1999; Marchini et al., 2001;
Nicholas, 1996). The IE-A locus shares positional, structural and
functional conservation despite low amino acid similarity. Thus,
we speculate that the U86 and U95 of PCMV might be the
IE-A genes.
The U16/17–19 of PCMV is homologous with IE-B genes of
HHV-6A, HHV-6B and HHV-7. These genes are the counterparts of
UL36–38 in HCMV, which are required for viral growth (Colberg-
Poley, 1996). In HCMV, the UL38 is recognized to prevent ER stress-
induced cell death (Qian et al., 2011) and the UL36 has been shown
to play a role in controlling cell death programs (McCormick et al.,
2010). Therefore, it is essential for exploring the roles of PCMV IE-B
genes in cellular apoptosis.
Genes associated with PCMV replication
The U27, U38, U41, U43, U73, U74 and U77 of PCMV have
homologs in HHV-6A, HHV-6B and HHV-7. These genes are
involved in origin binding and are essential for viral DNA replica-
tion in HHV-6A, HHV-6B and HHV-7 (Inoue and Pellett, 1995;
Isegawa et al., 1999; Nicholas, 1996). In HCMV, although the UL84
is essential for promoting lytic replication (Colletti et al., 2004;
Sarisky and Hayward, 1996), it has been shown to be dispensable
for the replication of the strain TB40/E clone (Spector and Yetming,
2010), implying that the absence of U55 (corresponding to UL84)
in PCMV might be reasonable. Similar to HHV-7, the U94 is absent
in the PCMV genome. This gene in HHV-6A and HHV-6B has been
recognized as the homolog of the adeno-associated virus Rep gene
(Thomson et al., 1994). The Rep protein has a role in viral latency
and it can inhibit the replication of HHV-7 and HCMV (Caselli
et al., 2006).
Genes associated with nucleotide metabolism and DNA repair
In PCMV, the genes including U28, U69, U70 and U81 are
homologs of HHV-6A, HHV-6B and HHV-7. These genes are
considered to be involved indirectly in DNA replication and are
associated with nucleotide metabolism and DNA repair (Isegawa
et al., 1999; Lindahl, 1979; Littler et al., 1992; Nicholas, 1996).
Thus, these homologous genes of PCMV are predicated to have
similar functions. The homologs of U45 and U55 of HHV-6A, HHV-
6B and HHV-7 are not present in the PCMV genome. The UL72 and
UL84 of HCMV, which are homologous with the U45 and U55 of
HHV-6A, HHV-6B and HHV-7, are shown to be the members of
the DURP gene family (Davison and Stow, 2005). The two genes
encode for inactive deoxyuridine triphosphatase (dUTPase)
(Caposio et al., 2004). The PCMV genes responsible for these
functions are required to be further investigated.
Glycoproteins of PCMV
The U39, U46, U48, U72 and U82 of PCMV have homologs in
HHV-6A, HHV-6B and HHV-7. These ORFs in HHV-6A, HHV-6B and
HHV-7 encode for glycoprotein B (gB), N (gN), H (gH), M (gM) and
L (gL), which play roles in virus entry and are required for virus
growth and maturation (Boehme et al., 2004; Feire et al., 2004;
Kawabata et al., 2012). The U100p of PCMV has no homologs in
herpesviruses and has a variety of predicted spliced patterns. In
HHV-6A and HHV-6B, the gQ (U100) is a unique glycoprotein that
controls viral attachment or entry by forming a complex of gH/gL/
Q1/Q2 (Akkapaiboon et al., 2004; Mori et al., 2003a, 2003b;
Tanaka et al., 2013). Because the amino acid sequence encoded
by the gQ gene and its spliced patterns are diverse among
betaherpesviruses, we speculated that the U100p of PCMV might
act as gQ.
Capsid, tegument, and virus assembly proteins of PCMV
Some homologs of PCMV core gene products are structural
proteins including capsid (encoded by U29, U32, U56, U57 and U76
in HHV-6A, HHV-6B and HHV-7), tegument (encoded by U28, U30,
Table 2
DNA repeats within the PCMV genome.
Name Locations Repeat size Copy number Percent matches
R1 102,291–102,342 14 3.6 92
R2 102,338–102,402 11 6 90
R3 103,149–103,177 15 1.9 100a
R4 103,780–103,812 15 2.3 94
R5 112,066–112,166 30 3.4 91
R6 114,286–114,413 54 2.4 83
R7 115,369–115,399 15 2.1 100a
R8 116,078–116,107 15 2.0 93
R9 116,110–116,164 3 18.3 85
R10 116,144–116,184 12 3.4 93
R11 117,823–118,209 100 3.9 100a
R12 118,338–118,483 74 2 88
R13 119,406–119,731 127 2.5 82
R14 122,790–122,819 14 2.1 93
R15 126,008–126,051 12 3.7 100a
DR 1–363, 128,005–128,367 363 2 100
a Perfect consecutive direct repeats.
Table 3
Predicted splice sites in the reported genes.
Genes Donor Acceptor
Location Sequence Score Location Sequence Score
U16/17 18,488\18,487 CATAT\GTAAGTA 0.98 18,406\18,407 TTTTTAG\TTGTG 0.97
U60/66 86,062\86,061 CGAAC\GTAAGTA 0.99 82,658\82,659 GCTATAG\ATTTC 0.92
U79 104,971\104,972 TGAAG\GTATGTG 0.99 105,042\105,043 TTTACAG\GCTGC 0.99
U89p/90p 115,845\115,844 TTCAG\GTAAGCC 1.00 114,514\114,515 ATCACAG\AGAGA 0.61
U100p 136,585\126,584 TCCTG\GTGAGCG 0.88
126,444\126,443 CGCAG\GTGAGAA 0.95 114,408\114,409 TCTTCAG\GTGAA 0.90
136,289\126,288 GAGAG\GTAAGAA 1.00 126,481\126,480 CCCACAG\CACCG 0.96
125,891\125,890 CCAAG\GTACATT 0.90 125,924\125,923 CCGGCAG\GTCAG 0.8
125,832\125,831 GACTC\GTAAGTA 0.98 125,736\125,735 ATTACAG\ATTTC 0.89
124,886\124,885 ATAAG\GTATATG 0.90 124,814\124,813 TTTACAG\CGAGA 0.65
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U31, U42, U44, U45, U49, U50, U59, U64, U65, U67, U69, U71 and
U75 in HHV-6A, HHV-6B and HHV-7) or envelope glycoproteins
(Isegawa et al., 1999; Nicholas, 1996). U2, U3, U11, U12, U14, U17,
U19, U25, U47, U51, U54, U68 and DR1 of HHV-6A, HHV-6B and
HHV-7 are structural genes at non-core blocks. All these genes are
homologs of PCMV except that U47 and DR1 are absent in PCMV.
Glycoprotein O (U47) of HHV-6A and 6B is involved in viral entry
by modifying the gH–gL complex (Mori et al., 2004). In HCMV, the
gO of Merlin strain is less efﬁcient than other gO isoforms in
competing for binding to gH/gL (Zhou et al., 2013). Thus, we
speculate that gH/gL of PCMV may bind with other proteins
instead. The products of PCMV U54A and U54B are two pp65
proteins, and their homologs are different in betaherpesviruses.
Additionally, no homologs to pp71 in HHV-6A, HHV-6B and HHV-7
were found in the PCMV genome. Previous studies have indicated
that the pp71 (UL82) and pp65 (UL83) of HCMV can interact with
different cellular proteins that regulate IE gene expression and
host immune response (Cantrell and Bresnahan, 2006; Cristea
et al., 2010). We speculate that the two pp65 proteins of PCMV
might have similar function.
Phylogentic analysis and classiﬁcation of PCMV
Phylogenetic analyses were performed based on the amino acid
sequences of the U38 (DPOL), U39 (gB), U43 (Helicase–primase
complex), U51 (G-protein coupled receptor), U57 (MCP), and U69
(VPK). The phylogenetic trees indicate that PCMV is clustered in a
branch together with HHV-6A, HHV-6B and HHV-7 (Fig. 3), and
meanwhile a newly recognized virus RfBHV-1 is in this branch only
based on its DPOL and gB, but these two viruses seem to form an
individual branch. In terms of phylogenetic analyses, PCMV could be
classiﬁed as a member of the genus Roseolovirus or assigned to a new
genus of the subfamily Betaherpesvirinae. Similarly, although RfBHV-1
is more closely related to roseoloviruses, it could also be assigned to
another new genus the subfamily Betaherpesvirinae. However, PCMV
is most closely related to HHV-6A, HHV-6B and HHV-7 in the
following aspects: (i) PCMV has similar genomic organization of
DR-U-DR to roseoloviruses; (ii) 69 ORFs of PCMV have counterparts
in roseoloviruses; (iii) the homologs of PCMV have greater simila-
rities with roseoloviruses; (iv) the homologous ORFs of PCMV possess
similar orientations and locations to HHV-6A, HHV-6B and HHV-7,
which are collinear relationship. The characteristic of viral genome is
considered as one of the most important standards in virus taxon-
omy of ICTV. Therefore, PCMV could be classiﬁed as a member of the
genus Roseolovirus and PCMV is a candidate for the ﬁrst classiﬁed
roseolovirus in swine.
Conclusion
Our analyses show that the genomic organization and gene
arrangement of PCMV shares a DR-U-DR type, similar to the
members of the genus Roseolovirus, and 69 of the predicted ORFs
in the PCMV genome have counterparts in HHV-6A, HHV-6B and
Fig. 3. Phylogenetic analysis of PCMV based on the deduced amino acid sequences of six genes. The analyzed genes are U38 (DPOL), U39 (gB), U43 (Helicase–primase
complex), U51 (G-protein coupled receptor), U57 (MCP), and U69 (VPK). Betaherpesviruses in ovals, hexagons, rectangles and triangles belong to roseolovirus,
muromegalovirus, cytomegalovirus, and proboscivirus, respectively. Phylogenetic analysis of RfBHV-1 based on the deduced amino acid sequences of DPOL and gB are
included in the trees of U38 and U39.
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HHV-7. Analyses of its genomic architecture, genetic content, and
phylogenetic relationships indicate that while somewhat an out-
lier, PCMV is most closely related to viruses that have been
assigned to the genus Roseolovirus within the subfamily Betaher-
pesvirinae, leading us to suggest that it would be appropriate for
the virus be formally assigned to the genus Roseolovirus.
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